English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/163397
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases

AuthorsPeñalver, Pablo ; Belmonte-Reche, Efres; Adán, Norma; Caro, Marta; Mateos-Martín María Luisa; Delgado, M. ; González-Rey, Elena; Morales, Juan C.
KeywordsInflammation
Neurodegenerative diseases
Neuroprotection
Prodrug
Resveratrol
Zebra fish
Issue Date25-Feb-2018
PublisherElsevier
CitationEuropean Journal of Medicinal Chemistry
AbstractResveratrol is a naturally occurring stilbene which has shown promising results as treatment for several neurodegenerative diseases. However, its application is limited due to its low efficacy and bioavailability. Here, we have designed and synthesized alkylated resveratrol prodrugs combining structural modification to improve antioxidant and anti-inflammatory properties and the preparation of prodrugs to extend drug bioavailability. For comparison we also studied resveratrol prodrugs and alkylated resveratrol derivatives. Methylated and butylated resveratrol derivatives showed the best in vitro neuroprotective and anti-inflammatory activity. The glucosyl- and glucosyl-acyl- prodrugs of these derivatives showed lower toxicity on zebra fish embryo. When neuroprotection was examined on pentylenetetrazole challenged zebra fish, they were capable of reverting neuronal damage but to a lower extent than resveratrol. Nevertheless, 3-O-(6'-O-octanoyl)-β-d-glucopyranoside resveratrol (compound 8) recovered AChE activity over 100% whereas resveratrol only up to 92%. In a 3-nitropropionic acid mice model of Huntington's disease, resveratrol derivative 8 delayed the onset and reduced the severity of HD-like symptoms, by improving locomotor activity and protecting against weight loss. Its effects involved an equal antioxidant but better anti-inflammatory profile than resveratrol as shown by SOD2 expression in brain tissue and circulating levels of IL-6 (11 vs 18 pg/mL), respectively. Finally, the octanoyl chain in compound 8 could be playing a role in inflammation and neuronal development indicating it could be acting as a double-drug, instead of as a prodrug
URIhttp://hdl.handle.net/10261/163397
DOI10.1016/j.ejmech.2018.01.037
ISSN0223-5234
E-ISSN1768-3254
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
EJMC2018_Peñalver et al_just accepted.pdf Embargoed until February 25, 20201,37 MBAdobe PDFThumbnail
View/Open    Request a copy
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.